Some experts say the move undermines science, disrupts a trusted regulatory process and could sow public distrust in ...

We recently wrote an introductory overview of navigating the Common Law Research Exemption and the Hatch-Waxman Safe Harbor ...

Rep. Mark Green (R-TN) on Thursday introduced legislation that seeks to increase accountability for vaccine manufacturers in the wake of allegations that such companies deliberately misled the public ...

"We remain confident in our intellectual property supporting the Pfizer/BioNTech vaccine and will vigorously defend against the allegations ... its patents for any COVID-19 vaccine used in the ...

WASHINGTON — The release of COVID-19 vaccine results after ... s development would be incorrect.” “Pfizer is in receipt of the letter asking about allegations made in a Wall Street Journal ...

Citing new information from British drugmaker GSK, U.S. lawmakers are pushing forward with a probe into a pandemic-era political controversy centered around the timing of trial results for Pfizer ...

A Pfizer spokesperson told CNN, “Pfizer is in receipt of the letter asking about allegations made in a Wall Street Journal story, and we will respond directly to the Committee.”“The COVID-19 vaccine ...

“Pfizer is in receipt of the letter asking about allegations made in a Wall Street Journal story, and we will respond directly to the Committee.”“The COVID-19 vaccine development process was ...